Massivemarkets

NYSE American: RGNT · Listed Dec 4, 2025

Regentis Biomaterials IPO

IPO price

$8.00

Regentis Biomaterials (RGNT) priced its IPO at $8.00 a share and has traded on NYSE American since Dec 4, 2025.

RGNT today$1.18-85.25%since IPO15-min delayed · as of 4:40:06 AM EST on Nov 19, 2026

See the RGNT quote

First trading day · Dec 4, 2025

IPO price 8.00VWAP 7.25first trade 7.40-7.50% from the IPO pricelow 7.00$7.25volume · rising bars above the line, falling bars below17.6K10:504:00
IPO price
$8.00
below the range of $10 to $12
First trade
$7.40
-7.50% from the IPO price
First-day last trade
$7.25
-9.38% from the IPO price, regular session
Raise
$10M
before the underwriters' option

These numbers are from the first trading day, Dec 4, 2025.

How RGNT did against the market

RGNT against the market, from its first trade at 10:50 ET to the last trade of the session.

RGNT from its first trade
-2.03%
Against the market (QQQ)
-2.1 pts

RGNT fell 2.0% from its first trade to the last trade of the session. That is 2.1 points worse than the market.

Same-day moves do not show that RGNT caused them. The market is QQQ, the Nasdaq-100 ETF.

The debut race

RGNT against other big listings, as the percent change from each stock's own IPO price.

The first 30 trading days. Each point is the last regular-session trade of a day.

+50%+100%+150%+200%+250%IPOday 1day 5day 10day 15day 20day 25day 30Figma '25 +69.64%Reddit '24 +40.32%CoreWeave '25 +28.42%Arm '23 -3.06%Klarna '25 -7.33%RGNT -13.50%

The IPO scoreboard

RGNT against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

RGNT against other big IPOs: the money raised, and the return from each IPO price at the first trade, at the last trade of day 1, and on day 5 and day 30.
IPORaisedFirst tradeDay 1 closeDay 1 close, as a barDay 5Day 30
Regentis Biomaterials '25$10M-7.50%-9.38%-11.25%-13.50%
Figma '25$1.22B+157.58%+252.42%+173.64%+69.64%
Circle '25$1.05B+122.58%+168.45%+278.18%+622.98%
Reddit '24$748M+38.24%+47.97%+69.90%+40.32%
Arm '23$5.23B+10.00%+23.76%+3.63%-3.06%
Klarna '25$1.37B+30.00%+16.14%+13.73%-7.33%
CoreWeave '25$1.5B-2.50%+0.02%+34.32%+28.42%

Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.

The offering

The Regentis Biomaterials IPO offers 1.25M shares to raise $10M, before any underwriters' option.

$8$10$11$12$14
Expected price range
$10 to $12
IPO price
$8.00
Shares offered
1.25M
Money raised
$10M
Listing date
Dec 4, 2025
Exchange
NYSE American
Security
Ordinary Shares

Money raised, against the largest IPOs

  • Alibaba '14$21.77B
  • Facebook '12$18.41B
  • Rivian '21$11.93B
  • Uber '19$8.1B
  • Arm '23$5.23B
  • Regentis Biomaterials$10M

Where RGNT ranks

Regentis Biomaterials's market cap against the largest US-listed companies.

Market cap, against the largest US-listed companies

  • AAPL$5.12T
  • MSFT$3.77T
  • NVDA$3.65T
  • GOOGL$3.47T
  • AMZN$2.9T
  • TSM$1.88T
  • AVGO$1.69T
  • META$1.58T
  • TSLA$1.52T
  • BRK.B$1.22T
  • RGNT$8.01M

RGNT news

The latest news and headlines about Regentis Biomaterials (RGNT).

Filings and the company

What Regentis Biomaterials has disclosed to the SEC, and the basic facts about the listing.

8-K filings

Material events that Regentis Biomaterials discloses to the SEC on Form 8-K.

No 8-K filings yet. A filing appears here after Regentis Biomaterials files it with the SEC.

About Regentis Biomaterials

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Ticker
RGNT
Exchange
NYSE American
Market
stocks
Type
CS
Currency
USD
Employees
8
Listed
Dec 4, 2025
Security
Ordinary Shares
Company website

Frequently asked questions

What was the Regentis Biomaterials IPO price?

$8.00 a share.

When did Regentis Biomaterials go public?

Regentis Biomaterials listed on NYSE American on Dec 4, 2025 under the ticker RGNT.

How much did the Regentis Biomaterials IPO raise?

$10M, before any underwriters' option.

How did Regentis Biomaterials open on its first day?

RGNT first traded at $7.40, -7.50% from the IPO price of $8.00.

How did RGNT close on its first day?

Its last regular-session trade was $7.25, -9.38% from the IPO price of $8.00.

What was the RGNT first-day trading range?

$6.96 to $7.50 in the regular session.

How many RGNT shares traded on the first day?

314.29K shares in the regular session.

How many shares did Regentis Biomaterials sell in its IPO?

1.25M shares.

How did RGNT do against the market on its first day?

RGNT fell 2.0% from its first trade to the last trade of the session. That is 2.1 points worse than the market (QQQ, the Nasdaq-100 ETF).

What exchange is RGNT listed on?

Regentis Biomaterials lists on NYSE American under the ticker RGNT.

Build with Massive

Get the RGNT data behind this page

The Massive endpoint behind each section of this page
What the page showsEndpoint
Offering terms and dates/vX/reference/ipos
Price/v3/snapshot
Chart, VWAP, and the market comparison/v2/aggs/ticker/RGNT/range/5/minute
Market cap/v3/reference/tickers/RGNT
News/v2/reference/news
Filings/vX/disclosures

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.